Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

741
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
741
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

687
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
687
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

787
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
787
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

760
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
760
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Minimalist Core and Lineage-Specific Expansion Underpin the Adaptive Evolution of the Cyclic Nucleotide-gated Channel (CNGC) Family: Insights from the Tea (<i>Camellia sinensis</i>) Pan-Genome.

Journal of agricultural and food chemistry·2026
Same author

Shading Influences the Adventitious Root Development of Winter Tea Cuttings Through Regulating Phytohormone Metabolism.

Physiologia plantarum·2026
Same author

Study on biosynthesis pathway and accumulation mechanism of the dihydrochalcones in <i>Lithocarpus litseifolius</i>.

Horticulture research·2026
Same author

Physical and Chemical Property Changes, Cooked-Off Flavor Formation, and Its Alleviation During Storage of Green Tea Beverages.

Foods (Basel, Switzerland)·2026
Same author

Phenotype, Squalene, and Lanosterol Content Variation Patterns During Seed Maturation in Different Leaf-Color Tea Cultivars.

Foods (Basel, Switzerland)·2026
Same author

Xenopax for the treatment of steroid-refractory acute graft-versus-host disease: the RELAX study.

Military Medical Research·2025

Related Experiment Video

Updated: Mar 2, 2026

Extraction and Analysis of Taiwanese Green Propolis
06:50

Extraction and Analysis of Taiwanese Green Propolis

Published on: January 7, 2019

9.3K

Antidiabetic Effects of Tea.

Qiu-Yue Fu1, Qing-Sheng Li2, Xiao-Ming Lin3

  • 1Tea Research Institute, Zhejiang University, Hangzhou 310058, China. 21516103@zju.edu.cn.

Molecules (Basel, Switzerland)
|May 23, 2017
PubMed
Summary

Tea consumption may help manage diabetes mellitus (DM), a chronic endocrine disease. This review examines evidence on tea

Keywords:
Camellia sinensiscaffeinediabetes mellitusepidemiological analysistea catechinstea polysaccharides

More Related Videos

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

11.2K

Related Experiment Videos

Last Updated: Mar 2, 2026

Extraction and Analysis of Taiwanese Green Propolis
06:50

Extraction and Analysis of Taiwanese Green Propolis

Published on: January 7, 2019

9.3K
An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

11.2K

Area of Science:

  • Endocrinology and Metabolism
  • Nutritional Science
  • Pharmacology

Background:

  • Diabetes mellitus (DM) is a major global health and economic burden.
  • DM results from insulin defects or resistance, leading to severe complications.
  • Tea's polyphenols and caffeine exhibit potential antidiabetic properties.

Purpose of the Study:

  • To review epidemiological evidence linking tea consumption to reduced diabetes risk.
  • To explore the underlying antidiabetic mechanisms of tea components.
  • To discuss inconsistencies in current research findings.

Main Methods:

  • Literature review of epidemiological studies on tea and diabetes.
  • Analysis of research on the biochemical mechanisms of tea's antidiabetic effects.
  • Critical evaluation of conflicting study results.

Main Results:

  • Inconsistent findings exist regarding tea consumption and diabetes risk reduction.
  • Tea polyphenols and caffeine show promise for antidiabetic activity.
  • Several factors may contribute to the variability in study outcomes.

Conclusions:

  • Tea holds potential for diabetes management, but evidence is mixed.
  • Further research is needed to clarify the relationship between tea and diabetes.
  • Understanding inconsistencies is crucial for developing effective tea-based interventions.